Daphne Koller, PhD: CEO and founder of insitro

Former Stanford University professor Daphne Koller's cutting edge work combines machine learning and biology to transform pharmaceutical drug development. Her work at insitro is part of an emerging field - digital biology - that is having an impact on multiple fields, including biomaterial design, agriculture, and human health. This MacArthur Fellow was also named one of TIME Magazine’s 100 most influential people. Click here for transcript of this episode. Kevin Scott